Robinson Smith Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$232K Sell
1,803
-1,954
-52% -$229K 0.14% 89
2026
Q1
$452K Hold
3,757
0.31% 51
2025
Q4
$396K Sell
3,757
-255
-6% -$23.9K 0.27% 56
2025
Q3
$337K Sell
4,012
-532
-12% -$43.8K 0.24% 63
2025
Q2
$360K Sell
4,544
-1,383
-23% -$110K 0.29% 57
2025
Q1
$532K Buy
5,927
+440
+8% +$41.1K 0.45% 45
2024
Q4
$546K Sell
5,487
-56
-1% -$5.77K 0.46% 43
2024
Q3
$630K Sell
5,543
-496
-8% -$58.9K 0.54% 42
2024
Q2
$748K Buy
6,039
+16
+0.3% +$2.06K 0.66% 39
2024
Q1
$795K Sell
6,023
-516
-8% -$63.6K 0.76% 35
2023
Q4
$713K Buy
+6,539
New +$679K 0.7% 36

Other funds holding MRK

Robinson Smith Wealth Advisors's MRK Position: Q2 2026 in Review

Robinson Smith Wealth Advisors reduced its Merck (MRK) stake by 52% in Q2 2026, selling an estimated $229K and leaving 1,803 shares worth $232K. The position accounts for 0.14% of the portfolio, ranked #89.

Robinson Smith Wealth Advisors first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $795K in Q1 2024. 2,371 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Robinson Smith Wealth Advisors held 1,803 shares of Merck worth $232K as of Q2 2026.
  • Robinson Smith Wealth Advisors sold 1,954 Merck shares in Q2 2026, an estimated $229K.
  • Merck made up 0.14% of Robinson Smith Wealth Advisors's portfolio in Q2 2026, its #89 holding.
  • Robinson Smith Wealth Advisors first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • Robinson Smith Wealth Advisors's Merck position peaked at $795K in Q1 2024.
  • 2,371 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Robinson Smith Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.